Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2721-50-8

Post Buying Request

2721-50-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2721-50-8 Usage

General Description

2,3-dihydroxyquinolin-4(1H)-one is a chemical compound with a heterocyclic structure containing a quinoline ring and two hydroxyl groups. It is also known as 2,3-dihydroxy-1,4-quinolinedione and is often used as a chelating agent in coordination chemistry. 2,3-dihydroxyquinolin-4(1H)-one has been studied for its potential biological activities, including antioxidant and antiproliferative properties. It has also been investigated for its potential role in the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's. Additionally, 2,3-dihydroxyquinolin-4(1H)-one has been recognized for its potential use as a corrosion inhibitor and as a building block in the synthesis of complex organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 2721-50-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,2 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2721-50:
(6*2)+(5*7)+(4*2)+(3*1)+(2*5)+(1*0)=68
68 % 10 = 8
So 2721-50-8 is a valid CAS Registry Number.

2721-50-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-dihydroxy-1H-quinolin-2-one

1.2 Other means of identification

Product number -
Other names 2,4-Quinolinetriol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2721-50-8 SDS

2721-50-8Relevant articles and documents

Kappe et al.

, p. 951 (1969)

Glycine receptor antagonist pharmacophore

-

, (2008/06/13)

Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer''s disease, amyotrophic lateral sclerosis, Huntington''s disease and Down''s syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions and inducing anesthesia are disclosed by administering to an animal in need of such treatment a compound which has high binding to the glycine receptor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2721-50-8